174 related articles for article (PubMed ID: 37606287)
1. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
[TBL] [Abstract][Full Text] [Related]
2. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
[TBL] [Abstract][Full Text] [Related]
4. External Validation of O-RADS US Risk Stratification and Management System.
Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of American College of Radiology Ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
[TBL] [Abstract][Full Text] [Related]
7. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
Yang Y; Ju H; Huang Y
Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
[TBL] [Abstract][Full Text] [Related]
10. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the diagnostic value of using serum CA125 and GI-RADS system in the evaluation of adnexal masses.
Zheng H; Tie Y; Wang X; Yang Y; Wei X; Zhao X
Medicine (Baltimore); 2019 Feb; 98(7):e14577. PubMed ID: 30762809
[TBL] [Abstract][Full Text] [Related]
12. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
Zhang Q; Dai X; Li W
AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
[No Abstract] [Full Text] [Related]
14. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
[TBL] [Abstract][Full Text] [Related]
15. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of the gynecology imaging reporting and data system (GI-RADS) with the ovarian malignancy marker CA-125 in preoperative adnexal tumor assessment.
Migda M; Bartosz M; Migda MS; Kierszk M; Katarzyna G; Maleńczyk M
J Ovarian Res; 2018 Nov; 11(1):92. PubMed ID: 30390688
[TBL] [Abstract][Full Text] [Related]
17. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
[TBL] [Abstract][Full Text] [Related]
18. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.
Jha P; Gupta A; Baran TM; Maturen KE; Patel-Lippmann K; Zafar HM; Kamaya A; Antil N; Barroilhet L; Sadowski EA
JAMA Netw Open; 2022 Jun; 5(6):e2216370. PubMed ID: 35679042
[TBL] [Abstract][Full Text] [Related]
20. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
Poonyakanok V; Tanmahasamut P; Jaishuen A
J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]